Clinical Trial Update: Postoperative Concurrent Chemoradiation for Head and Neck Cancer With Multiple Minor Risk [NA]

View source ↗

Summary

A clinical trial evaluating postoperative concurrent chemoradiation for head and neck squamous cell carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Head and Neck Neoplasms, Carcinoma, Squamous Cell | NA | Status: TERMINATED